Growth Metrics

Pfizer (PFE) Cash from Discontinued Operations (2020 - 2022)

Pfizer (PFE) has disclosed Cash from Discontinued Operations for 9 consecutive years, with 5000000.0 as the latest value for Q3 2022.

  • Quarterly Cash from Discontinued Operations fell 129.41% to 5000000.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was 332000000.0 through Oct 2022, down 115.84% year-over-year, with the annual reading at 343000000.0 for FY2021, 108.88% down from the prior year.
  • Cash from Discontinued Operations for Q3 2022 was 5000000.0 at Pfizer, up from 327000000.0 in the prior quarter.
  • The five-year high for Cash from Discontinued Operations was 2414000000.0 in Q3 2020, with the low at 327000000.0 in Q4 2021.
  • Average Cash from Discontinued Operations over 3 years is 564428571.43, with a median of 17000000.0 recorded in 2021.
  • The sharpest move saw Cash from Discontinued Operations crashed 98.07% in 2021, then tumbled 129.41% in 2022.
  • Over 3 years, Cash from Discontinued Operations stood at 2414000000.0 in 2020, then crashed by 113.55% to 327000000.0 in 2021, then soared by 98.47% to 5000000.0 in 2022.
  • According to Business Quant data, Cash from Discontinued Operations over the past three periods came in at 5000000.0, 327000000.0, and 17000000.0 for Q3 2022, Q4 2021, and Q3 2021 respectively.